Search Results - "DE Jesus Dos Santos, Talyta Ellen"
-
1
Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
Published in Clinics (São Paulo, Brazil) (2019)“…To evaluate the effects of epoetin (EPO) alfa treatment on overall survival, event-free survival and response duration in patients with myelodysplastic…”
Get full text
Journal Article -
2
Clinical events and their relation to the tumor necrosis factor-alpha and interleukin-10 genotypes in Sickle-Cell-Anemia patients
Published in Hematology/oncology and stem cell therapy (01-03-2016)“…Abstract Objective/background Sickle-cell anemia (SCA) is a genetic blood disease characterized by chronic inflammation and a heterogeneous clinical picture…”
Get full text
Journal Article -
3
Methemoglobin measure in adult patients with sickle-cell anemia: influence of hydroxyurea therapy
Published in Jornal brasileiro de patologia e medicina laboratorial (01-06-2014)“…Introduction: Hemoglobin S (HbS) is unstable hemoglobin that easily oxidizes, causing methemoglobin (MetHb) increased production in patients with sickle-cell…”
Get full text
Journal Article -
4
Monocyte chemoatractant protein-1: A potential biomarker of renal lesion and its relation with oxidative status in sickle cell disease
Published in Blood cells, molecules, & diseases (01-03-2015)“…The aim of this study was to evaluate the monocyte chemoatractant protein-1 (MCP-1) as a novel biomarker of renal lesion in sickle cell disease (SCD) and…”
Get full text
Journal Article -
5
Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
Published in Journal of medical case reports (21-05-2017)“…Myelodysplastic syndromes are heterogeneous disorders. Patients with myelodysplastic syndrome disease often have ineffective hematopoiesis, cytopenias, blood…”
Get full text
Journal Article -
6
Presence of CD34 + in Megakaryocytes in Association With p53 Expression Predicts Unfavorable Prognosis in Low-risk Myelodysplastic Syndrome Patients
Published in In vivo (Athens) (01-01-2019)“…Although risk stratification using the Prognostic Scores Systems (IPSS, WPSS and IPSS-R) incorporate key information about prognosis of patients with…”
Get full text
Journal Article -
7
The role of iron overload on oxidative stress in sickle cell anemia
Published in Biomarkers in medicine (01-12-2012)“…Repeated blood transfusions in patients with sickle cell anemia (SCA) increases the risk of iron overload (IO), contributing to oxidative stress. Blood samples…”
Get more information
Journal Article -
8
Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
Published in Revista brasileira de hematologia e hemoterapia (01-05-2014)“…At the time of diagnosis, more than 50% of patients with myelodysplastic syndrome have a normal karyotype and are classified as having a favorable prognosis…”
Get full text
Journal Article -
9
-
10
The Effect of a Selective Inhibitor of Phosphodiesterase‐9 on Oxidative Stress, Inflammation and Cytotoxicity in Neutrophils from Patients with Sickle Cell Anaemia
Published in Basic & clinical pharmacology & toxicology (01-04-2016)“…The aim of the study was to investigate the possible anti‐inflammatory and antioxidant effects of BAY 73‐6691 on neutrophils from SCA patients. This study…”
Get full text
Journal Article -
11
Comparative Outcomes for HLA-Matched Siblings, Mismatched, and Haploidentical Donors in Myelodisplastic Syndromes: Report from the Latin American Register
Published in Transplantation and cellular therapy (01-02-2024)“…Allogeneic stem cell transplantation (allo-HSCT) remains the only curative treatment for Myelodisplastic Syndromes (MDS) and many factors may predict outcomes…”
Get full text
Journal Article -
12
403 - In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?
Published in Transplantation and cellular therapy (01-02-2023)Get full text
Journal Article -
13
In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?
Published in Transplantation and cellular therapy (01-02-2023)Get full text
Journal Article -
14
Wernicke's encephalopathy in a patient with non-Hodgkin's lymphoma post-Autologous HSCT
Published in Revista da Associacao Medica Brasileira (1992) (01-10-2018)“…Wernick's Encephalopathy (WE) is an acute neuropsychiatric syndrome caused by thiamine deficiency post hematopoietic stem cell transplant (HSCT). WE is…”
Get full text
Magazine Article -
15
Association of oxidative stress and DNA damage with grafting time in patients with multiple myeloma and lymphoma submitted to autologous hematopoietic stem cell transplantation
Published in Revista da Associacao Medica Brasileira (1992) (01-10-2016)“…The aim of the study was to investigate the association between oxidative stress and DNA damage with grafting time in patients submitted to autologous…”
Get full text
Magazine Article -
16
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
Published in Revista da Associacao Medica Brasileira (1992) (01-10-2016)“…The hematopoietic stem cell transplantation (HSCT) is the only curative alternative for Myelodysplastic Syndrome (MDS), but many patients are not eligible for…”
Get full text
Magazine Article -
17
-
18